| Income Statement |
| Total Revenue | 318.99M |
|
| Revenues (USD) | 318.99M |
| Cost of Revenue | 134.37M |
| Gross Profit | 184.62M |
| Operating Expenses | 221.47M |
| Research and Development Expense | 5.35M |
| Selling, General and Administrative Expense | 194.39M |
| Operating Income | -36.86M |
| Interest Expense | 13.10M |
| Income Tax Expense | 338.00K |
| Net Income | -50.30M |
| Net Income Common Stock | -50.30M |
| Net Income Common Stock (USD) | -50.30M |
| Consolidated Income | -50.30M |
| Earnings per Basic Share | -2.19 |
| Earnings per Basic Share (USD) | -2.19 |
| Earnings per Diluted Share | -2.19 |
| Earning Before Interest & Taxes (EBIT) | -36.86M |
| Earning Before Interest & Taxes (USD) | -36.86M |
| Weighted Average Shares | 22.99M |
| Weighted Average Shares Diluted | 22.99M |
| Balance Sheet |
| Cash and Equivalents | 1.48M |
| Cash and Equivalents (USD) | 1.48M |
| Trade and Non-Trade Receivables | 13.35M |
| Current Assets | 143.48M |
| Property, Plant & Equipment Net | 369.07M |
| Total Assets | 641.01M |
| Debt Current | 684.94M |
| Total Debt | 953.64M |
| Current Liabilities | 931.71M |
| Debt Non-Current | 268.70M |
| Total Liabilities | 1.27B |
| Accumulated Retained Earnings (Deficit) | -661.45M |
| Shareholders Equity | -626.32M |
| Shareholders Equity (USD) | -626.32M |
| Assets Non-Current | 497.53M |
| Total Debt (USD) | 953.64M |
| Deferred Revenue | 43.34M |
| Goodwill and Intangible Assets | 66.13M |
| Inventory | 78.22M |
| Liabilities Non-Current | 335.62M |
| Trade and Non-Trade Payables | 116.40M |
| Tax Assets | 399.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 12.37M |
| Net Cash Flow from Financing | 12.98M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -209.00K |
| Capital Expenditure | -5.44M |
| Issuance (Purchase) of Equity Shares | -373.00K |
| Issuance (Repayment) of Debt Securities | 13.36M |
| Net Cash Flow from Investing | -5.44M |
| Net Cash Flow from Operations | -7.75M |
| Share Based Compensation | 2.83M |